New Delhi, Mar 20: Jamia Millia Islamia has lauded the work on CAR T-cell therapy carried out by Dr Tanveer Ahmed, a Kashmiri scientist working at the University and first author Dr Areej Akhtar. CAR T-cell is a groundbreaking treatment that has transformed the fight against blood cancers like leukemia and lymphoma. This therapy involves engineering the patient’s own T-cells to recognize and kill cancer cells.
One of the most well-known success stories of CAR T-cell therapy is Emily Whitehead, the first child to receive this treatment in a clinical trial. She had a severe form of leukemia, and after receiving CAR T-cell therapy in April 2012, she has remained cancer-free for over a decade now, inspiring hope worldwide.
The current CAR T-cell therapies available in India and abroad are 2nd generation.
Researchers at Jamia Millia Islamia’s Multidisciplinary Centre for Advanced Research & Studies (MCARS) have taken this therapy a step further, read a statement, issued by the varsity.
Their latest study, which is now published in the prestigious journal Cell Reports Medicine, focuses on 4th generation CAR T-cell therapy, which is a highly advanced version of the previous generations.
